Effect of genetic variations on ticagrelor plasma levels and clinical outcomes-Reference-Cited by-同舟云学术

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Published:2015-05-02 Issue:29 Volume:36 Page:1901-1912
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Varenhorst Christoph,Eriksson Niclas,Johansson Åsa,Barratt Bryan J.,Hagström Emil,Åkerblom Axel,Syvänen Ann-Christine,Becker Richard C.,James Stefan K.,Katus Hugo A.,Husted Steen,Steg Ph. Gabriel,Siegbahn Agneta,Voora Deepak,Teng Renli,Storey Robert F.,Wallentin Lars

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/29/1901/17154684/ehv116.pdf

Reference25 articles.

1. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

2. Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist

3. Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation

4. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

5. Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications;Interventional Cardiology Clinics;2024-10

2. Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome;Int. Journal of Clinical Pharmacology and Therapeutics;2024-09-01

3. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

4. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

5. Retraction of: Associations Between Ticagrelor Use and the Risk of Infections: A Mendelian Randomization Study;The Journal of Infectious Diseases;2024-08-06